Literature DB >> 34185108

[Atrial fibrillation].

Renate B Schnabel, Andreas Rillig, Paulus Kirchhof1.   

Abstract

Atrial fibrillation is frequent and has severe sequelae, such as stroke, cardiovascular death and cardiac insufficiency. These sequelae can be effectively reduced by anticoagulants, a meticulous recognition and treatment of cardiovascular comorbidities and an early rhythm-preserving treatment. Catheter ablation leads to a better preservation of the sinus rhythm and in symptomatic patients to a better quality of life in comparison to treatment with antiarrhythmic agents. This should be included in the planning of early rhythm-maintaining treatment.

Entities:  

Keywords:  Antiarrhythmic therapy; Anticoagulant; Atrial fibrillation; Catheter ablation; Stroke

Year:  2021        PMID: 34185108     DOI: 10.1007/s00108-021-01067-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  5 in total

1.  Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.

Authors:  Larissa Fabritz; Harry J G M Crijns; Eduard Guasch; Andreas Goette; Karl Georg Häusler; Dipak Kotecha; Thorsten Lewalter; Christian Meyer; Tatjana S Potpara; Michiel Rienstra; Renate B Schnabel; Stephan Willems; Guenter Breithardt; A John Camm; Anthony Chan; Winnie Chua; Mirko de Melis; Christina Dimopoulou; Dobromir Dobrev; Christina Easter; Lars Eckardt; Doreen Haase; Stephane Hatem; Jeff S Healey; Jordi Heijman; Stefan H Hohnloser; Thomas Huebner; Bushra Saeed Ilyas; Aaron Isaacs; Ingo Kutschka; Christophe Leclercq; Gregory Y H Lip; Elena Andreassi Marinelli; Jose L Merino; Lluís Mont; Michael Nabauer; Jonas Oldgren; Helmut Pürerfellner; Ursula Ravens; Irina Savelieva; Moritz F Sinner; Alice Sitch; Rüdiger Smolnik; Jan Steffel; Kenneth Stein; Monika Stoll; Emma Svennberg; Dierk Thomas; Isabelle C Van Gelder; Burcu Vardar; Reza Wakili; Mattias Wieloch; Stef Zeemering; Paul D Ziegler; Hein Heidbuchel; Gerhard Hindricks; Ulrich Schotten; Paulus Kirchhof
Journal:  Europace       Date:  2021-03-08       Impact factor: 5.214

2.  Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.

Authors:  Jason G Andrade; George A Wells; Marc W Deyell; Matthew Bennett; Vidal Essebag; Jean Champagne; Jean-Francois Roux; Derek Yung; Allan Skanes; Yaariv Khaykin; Carlos Morillo; Umjeet Jolly; Paul Novak; Evan Lockwood; Guy Amit; Paul Angaran; John Sapp; Stephan Wardell; Sandra Lauck; Laurent Macle; Atul Verma
Journal:  N Engl J Med       Date:  2020-11-16       Impact factor: 91.245

3.  Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation.

Authors:  Oussama M Wazni; Gopi Dandamudi; Nitesh Sood; Robert Hoyt; Jaret Tyler; Sarfraz Durrani; Mark Niebauer; Kevin Makati; Blair Halperin; Andre Gauri; Gustavo Morales; Mingyuan Shao; Jeffrey Cerkvenik; Rachelle E Kaplon; Steven E Nissen
Journal:  N Engl J Med       Date:  2020-11-16       Impact factor: 91.245

4.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

5.  Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe.

Authors:  Renate B Schnabel; Ladislav Pecen; Nargiz Rzayeva; Markus Lucerna; Yanish Purmah; Francisco M Ojeda; Raffaele De Caterina; Paulus Kirchhof
Journal:  J Am Heart Assoc       Date:  2018-05-18       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.